Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Influenza hemagglutinin vaccine with poly(gamma-glutamic acid) nanoparticles enhances the protection against influenza virus infection through both humoral and cell-mediated immunity.

Influenza hemagglutinin vaccine with poly(gamma-glutamic acid) nanoparticles enhances the protection against influenza virus infection through both humoral and cell-mediated immunity. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Influenza hemagglutinin vaccine with poly(gamma-glutamic acid) nanoparticles enhances the protection against influenza virus infection through both humoral and cell-mediated immunity. Abstract Text:

    shigefumi okamotoShigefumi Okamoto,hironori yoshiiHironori Yoshii,takami akagiTakami Akagi,mitsuru akashiMitsuru Akashi,toyokazu ishikawaToyokazu Ishikawa,yoshinobu okunoYoshinobu Okuno,michiaki takahashiMichiaki Takahashi,koichi yamanishiKoichi Yamanishi,yasuko moriYasuko Mori,shigefumi okamotoShigefumi Okamoto,hironori yoshiiHironori Yoshii,takami akagiTakami Akagi,mitsuru akashiMitsuru Akashi,toyokazu ishikawaToyokazu Ishikawa,yoshinobu okunoYoshinobu Okuno,michiaki takahashiMichiaki Takahashi,koichi yamanishiKoichi Yamanishi,yasuko moriYasuko Mori,

    Subcutaneous immunization with an influenza hemagglutinin (HA) vaccine can induce the production of virus-neutralizing antibodies, but not a cell-mediated immune response. Here we tested whether amphiphilic poly(gamma-glutamic acid)-graft-l-phenylalanine copolymers (gamma-PGA-NPs), which are derived from a bacterial capsular exopolymer produced by certain Bacillus natto strains, were an effective adjuvant for systemic influenza HA vaccination. Subcutaneous immunization with a mixture of HA vaccine and gamma-PGA-NPs induced higher mononuclear cell proliferation and the production of gamma-interferon (IFN-gamma), interleukin (IL)-4, and IL-6 upon HA restimulation, and enhanced not only anti-HA neutralizing antibody production but also the influenza virus-specific cell-mediated immune response, including CTL activity, compared with immunization with HA alone or a mixture of HA and aluminum adjuvant. HA vaccine with gamma-PGA-NPs protected mice against challenges with lethal doses of homologous influenza virus. The results indicate that adding gamma-PGA-NPs to the HA vaccine promotes effective protection and identifies gamma-PGA-NPs as a new, effective, and potent candidate adjuvant for a subcutaneous influenza virus vaccine.

    Influenza hemagglutinin vaccine with poly(gamma-glutamic acid) nanoparticles enhances the protection against influenza virus infection through both humoral and cell-mediated immunity. Publishing Authors By Initials

    s okamotoS Okamoto,h yoshiiH Yoshii,t akagiT Akagi,m akashiM Akashi,t ishikawaT Ishikawa,y okunoY Okuno,m takahashiM Takahashi,k yamanishiK Yamanishi,y moriY Mori,s okamotoS Okamoto,h yoshiiH Yoshii,t akagiT Akagi,m akashiM Akashi,t ishikawaT Ishikawa,y okunoY Okuno,m takahashiM Takahashi,k yamanishiK Yamanishi,y moriY Mori,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Influenza hemagglutinin vaccine with poly(gamma-glutamic acid) nanoparticles enhances the protection against influenza virus infection through both humoral and cell-mediated immunity. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Vaccine

    VOLUME: 25

    Page Numbers: 8270-8

    Journal Abbreviation: Vaccine

    ISSN: 0264-410X

    DAY: 11

    MONTH: 10

    YEAR: 2007

    Influenza hemagglutinin vaccine with poly(gamma-glutamic acid) nanoparticles enhances the protection against influenza virus infection through both humoral and cell-mediated immunity. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8406899

    Influenza hemagglutinin vaccine with poly(gamma-glutamic acid) nanoparticles enhances the protection against influenza virus infection through both humoral and cell-mediated immunity. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Influenza hemagglutinin vaccine with poly(gamma-glutamic acid) nanoparticles enhances the protection against influenza virus infection through both humoral and cell-mediated immunity. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Influenza hemagglutinin vaccine with poly(gamma-glutamic acid) nanoparticles enhances the protection against influenza virus infection through both humoral and cell-mediated immunity.

    AFFILIATION: Laboratory of Virology and Vaccinology, Division of Biomedical Research, National Institute of Biomedical Innovation, 7-6-8 Saito-Asagi, Ibaraki, Osaka 567-0085, Japan.

    Country: Netherlands

    Netherlands Research PublicationNetherlands Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Vaccine

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Influenza hemagglutinin vaccine with polygamma-glutamic acid nanoparticles enhances the protection against influenza virus infection through both humoral and cell-mediated immunity Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News